Medical Center of Central Georgia Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2007
NCT00431379
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

alteplase (Activase) (1 trial)

Drugs in Phase 1 Trials (1)

tenecteplase (tnkase) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 1)

Embolism (Phase 3)

Pulmonary Embolism (Phase 3)

Respiratory Distress Syndrome (Phase 1)

Respiratory Distress Syndrome, Newborn (Phase 1)

Syndrome (Phase 1)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2